Masami Kawagishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Masami Kawagishi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Akihiro Koga
Canon Medical Systems Corporation, Tochigi, Japan
1 shared publication - Daan Willem Loth
Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands
1 shared publication - Daniel Bos
Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands
1 shared publication - David Chistopher Christiani
39Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
1 shared publication - Gary Matt Hunninghake
Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
1 shared publication - Gunnar Gudmundsson
Faculty of Medicine, University of Iceland, Reykjavik, Iceland
1 shared publication
Latest Publications
- Open Access
- 11 December 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (4) , 660-672
Automated interstitial lung abnormalities detection at CT: external validation and potential recognition of traction bronchiectasis/bronchiolectasis
Purpose: An artificial intelligence (AI) system for detecting interstitial lung abnormalities (ILA) was previously developed but requires external validation. This study aimed to examine the robustness across different populations and investigate associations between the system outputs and traction bronchiectasis/bronchiolectasis severity patterns. Materials and methods: CT scans from population-based samples of the Rotterdam Study (2018–2019) and the Age Gene/Environment Susceptibility Reykjavik (AGES-Reykjavik) Study (baseline CT: 2002–2006, follow-up CT: 2007–2011) were used in this secondary analysis of the two cohorts. The AI system calculated ILA probability score (AI score) in the range from 0 to 1. Three experienced readers evaluated independently all CT scans for ILA, and two chest radiologists assessed traction bronchiectasis/bronchiolectasis using the 4-scale traction bronchiectasis/bronchiolectasis index (TBI) for severity by consensus. Receiver operating characteristic (ROC) analysis and Kruskal–Wallis test were used for statistical analysis. Results: The system analyzed 932 CT scans of the Rotterdam Study (mean participant age, 79.6 years ± 4.3 (SD), 482 women) and 5242 CT scans of the AGES-Reykjavik Study (mean participant age, 76.4 years ± 5.6, 3032 women), and achieved area under the ROC curve of 0.841 (95% CI 0.804, 0.879) and 0.823 (95% CI 0.798, 0.847), respectively. AI scores correlated with readers’ certainty, decreasing from unanimous ILA cases to No-ILA cases. Higher baseline AI scores correlated with greater severity of traction bronchiectasis/bronchiolectasis (TBI-3: 0.931 [IQR, 0.911–0.932], TBI-2: 0.738 [IQR, 0.406–0.880], TBI-1: 0.537 [IQR, 0.317–0.761], TBI-0: 0.250 [IQR, 0.136–0.455]). Conclusion: The system demonstrated robust ILA detection performance across different populations, with AI scores showing associations with traction bronchiectasis/bronchiolectasis severity.
- 11 December 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (4) , 660-672
Open AccessAutomated interstitial lung abnormalities detection at CT: external validation and potential recognition of traction bronchiectasis/bronchiolectasis
Purpose: An artificial intelligence (AI) system for detecting interstitial lung abnormalities (ILA) was previously developed but requires external validation. This study aimed to examine the robustness across different populations and investigate associations between the system outputs and traction bronchiectasis/bronchiolectasis severity patterns. Materials and methods: CT scans from population-based samples of the Rotterdam Study (2018–2019) and the Age Gene/Environment Susceptibility Reykjavik (AGES-Reykjavik) Study (baseline CT: 2002–2006, follow-up CT: 2007–2011) were used in this secondary analysis of the two cohorts. The AI system calculated ILA probability score (AI score) in the range from 0 to 1. Three experienced readers evaluated independently all CT scans for ILA, and two chest radiologists assessed traction bronchiectasis/bronchiolectasis using the 4-scale traction bronchiectasis/bronchiolectasis index (TBI) for severity by consensus. Receiver operating characteristic (ROC) analysis and Kruskal–Wallis test were used for statistical analysis. Results: The system analyzed 932 CT scans of the Rotterdam Study (mean participant age, 79.6 years ± 4.3 (SD), 482 women) and 5242 CT scans of the AGES-Reykjavik Study (mean participant age, 76.4 years ± 5.6, 3032 women), and achieved area under the ROC curve of 0.841 (95% CI 0.804, 0.879) and 0.823 (95% CI 0.798, 0.847), respectively. AI scores correlated with readers’ certainty, decreasing from unanimous ILA cases to No-ILA cases. Higher baseline AI scores correlated with greater severity of traction bronchiectasis/bronchiolectasis (TBI-3: 0.931 [IQR, 0.911–0.932], TBI-2: 0.738 [IQR, 0.406–0.880], TBI-1: 0.537 [IQR, 0.317–0.761], TBI-0: 0.250 [IQR, 0.136–0.455]). Conclusion: The system demonstrated robust ILA detection performance across different populations, with AI scores showing associations with traction bronchiectasis/bronchiolectasis severity.